NICE's advice programmes consists of a range of products that are either based on NICE guidance or involve a critical assessment of relevant evidence. However, these products do not have the status of formal NICE guidance, and do not contain new NICE recommendations.

Evidence summaries

Summaries of the best available evidence to inform local NHS planning and decision-making, for selected new medicines, off-label use of licensed medicines and unlicensed medicines.

Evidence summaries:

  • inform national commissioning decisions about medicines, for example by NHS England

  • provide information for healthcare professionals to inform their decision-making and support the development and updating of local formularies

  • help inform the public about a medicine and condition to help them make decisions about the medicine

  • provide information about an unlicensed medicine or off-label use of a licensed medicine that is being considered when there are no suitable alternatives licensed for that situation.

More information

Our process guide sets out how we select topics and prepare the summaries.

Read more about evidence summaries

View evidence summaries

Key therapeutic topics (KTTs)

Key therapeutic topics summarise the evidence-base on topics identified to support medicines optimisation.

Local government briefings (LGBs)

Advice for local government on the public health actions that are most effective and provide best value for money.

Medtech innovation briefings (MIBs)

Objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals.

IAPT assessment briefings

Improving Access to Psychological Therapies (IAPT) services provide evidence-based therapies to people with anxiety, depression and medically unexplained symptoms. We assess digitally enabled therapies which offer the potential to expand these services further.